881639-98-1,
GPR30 Agonist, G-1,
G-1,
AC1MJFYZ,
GPR30 inhibitor G1,
MLS001242405,
CHEMBL1434839,
SCHEMBL12700947,
CTK8E7016,
DTXSID10389691,
CHEBI:123624,
HMS2225M10,
AKOS025295869,
MCULE-7477421383,
BAS 02002377,
SMR001227330,
RT-013112,
EU-0081217,
UNM000011069001,
1-[(3aR,4S,9bS)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone,
1-[4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone,
1-[4-(6-Bromo-2H-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethan-1-one,
4-(6-Bromo-1,3-benzodioxole-5-yl)-8-acetyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline,
VHSVKVWHYFBIFJ-UHFFFAOYSA-N,
ZINC04959603,
CID3136849,
1-((3aS,4R,9bR)-4-(6-bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)ethanone,
1-(4-(6-Bromobenzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)-ethanone,